Bluelight.org

Cannabis Discussion (CD) is dedicated to the discussion of cannabis and is also the official home to synthetic cannabinoid discussion. Intelligent discussion of both basic and advanced cannabis related topics is encouraged. However, please resist the urge to post discussions like "Best Muchies" or "Best music to listen to while stoned", discussions like that are best suited for Drug Culture. How ever we do have a great social thread where your free to tell us what your snacking on while your smoking, or if you just want to say "whats up mannnnnn?" Check it out: CD Social

If its your first time to CD I recommend you check out our wonderful CD Directory! Filled with links to all our current Mega Threads and other threads of interest. Here in CD we like to keep things organized, cause when your stoned its hard to find shit. To do that we have a collection of Mega Threads with the prefix [MEGA] so there is no missing them. We ask that before you start a new thread, check to see if...

Global Drug Survey has partnered with Bluelight to create a sample of people who reported using Bluelight in the last 7 days.
This report is based on the data from 1480 people who used Bluelight in the last 7 days and completed GDS up to and including questions about novel substance use.
The survey was live in November-December 2017.

Summary of results:

Most Bluelighters (70% ) come from English-speaking countries (US, UK, Australia, Canada)
Bluelighters are typically young 'white' males (median age 20, 84% male, 88% 'White')
Over half of Bluelighters are currently studying (56% )
A quarter (24% ) have completed a university qualification
Half (51% ) report being in paid employment, including 28% that work full-time
20% report their occupation as 'professional'
Almost half (45% ) report 'never' going clubbing
Lifetime drug use rates include 94% cannabis, 71% LSD and 68% MDMA
Lifetime use of prescription benzodiapines (64% ) and opioids (60% ) is significant
Lifetime rates of...

Forum Focus Month Jan/Feb 2018: Come Discuss Science & Film!



This is a new way of trying to promote lesser used (and often once thriving) sub-forums here on bluelight: forum focus months. Basically the idea is to try and give certain forums a bit of steam by cataloguing and encouraging use in some of their interesting and engaging threads.

For January/February, the forums will be Science & Technology and Film & Television.

Both forums have seen quite an upsurge in posts recently, and we'd like to promote both of them.

Science & Technology Active Threads Jan/Feb 2018:
Come and discuss science stuff in the following threads:

BITCOIN Discussion v. 8 Coins on an Old Computer
Why are we so eager to believe in extraterrestrial life?
New Solar System Like Our Own Discovered
Which CRYPTOCURRENCY Will Post The Most GAINS By 2020?
Why We May Soon Be Trapped on Earth
BUYING Bitcoin
Mysterious explosion of c. diff bacteria caused by increased consumption of a sugar...

GDS / Bluelight census



In partnership with Global Drug Survey, Bluelight is launching its own census. That's right, we want to know a bit more about our community. Things like demographics and drug use characteristics. And whether you use harm reduction information from website to inform what decisions you make.

This year, Global Drug Survey included an item asking whether people had accessed certain drug-related websites ever and in the last 7 days. So by partnering with GDS, we will be able to draw the sample of people who report using Bluelight in the last 7 days from the larger sample, and produce a short report on their data.

We will post that report to Bluelight's front page by February 2018. The report will be short, focusing on demographics, drug use statistics, rates of harm (e.g. emergency attendance), and use of harm reduction strategies.

GDS / Bluelight census

Notes

You do not have to complete every section of GDS to be part of the census...

the forums are back after a short interruption.

thanks.

alasdair

Currently we have 4 surveys on the go where the universities have donated to Bluelight. They have helped us upgrade the servers!!! So please consider completing these surveys, if you haven't done so already, and if you are eligible. Thanks so much for your support

Do you live in the US and have you ever used Tapentadol, otherwise known as Nucynta, Palexia and Tapal, even just once?
Click here for survey on Tapentadol

Have you used synthetic cannabis (such as spice, K2, noids, Black Mamba, Mad Hatter, JWH, CHMINACA) even just once in your lifetime?
Click here for survey on synthetic cannabis

Do you live in the UK and have you used mephedrone in the last 12 months?
Click here for UK survey about mephedrone

Do you live in the UK and have you used synthetic cannabinoids in the last 12 months?
Click here for UK survey about synthetic cannabinoids

Image from page 1011 of 'The Pharmaceutical era' (1887) by Internet Archive Book Images, on Flickr

tl;dr – NBOMe mixtures sold as MDMA are around, don’t snort unknown caps, use test-kits wisely, look after your mates, and get your lab student/worker friends to contact us so we don’t need to rely on labs in Barcelona to access high-quality drug testing in Australia!

On the weekend 15-16 January 2017, there was a spate of poisonings, hospitalisations and deaths that have been associated a batch of capsules that were reportedly sold as MDMA or Ecstasy. Punters at Revolver nightclub and other clubs on Melbourne’s Chapel Street were affected.

The contents of these caps appeared damp, more like a brown sugar consistency than crystals or powder.



We obtained anonymous reports from people who consumed these capsules. The reports describe very strong hallucinogenic symptoms and paranoia. While in most cases, the symptoms resolved without medical intervention, they were very unpleasant, with one person reporting that they ‘felt like they were going to die or never be the...

F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients

https://static01.nyt.com/images/2016/11/26/us/26ecstasy1/26ecstasy1-master768.jpg

C.J. Hardin, a veteran who served three tours in Iraq and Afghanistan, at a memorial in North Charleston, S.C. He is a patient in the study of MDMA, also known as Ecstasy, as a treatment for post-traumatic stress disorder.

CHARLESTON, S.C. — After three tours in Iraq and Afghanistan, C. J. Hardin wound up hiding from the world in a backwoods cabin in North Carolina. Divorced, alcoholic and at times suicidal, he had tried almost all the accepted treatments for post-traumatic stress disorder: psychotherapy, group therapy and nearly a dozen different medications.

“Nothing worked for me, so I put aside the idea that I could get better,” said Mr. Hardin, 37. “I just pretty much became a hermit in my cabin and never went out.”

Then, in 2013, he joined a small drug trial testing whether PTSD could be treated with MDMA, the...

Please welcome toscablue (Nadine van Gelder) to the Bluelight research assistant position, who will also have a moderating role on Drug Studies.

toscablue will help me liaise with researchers who may wish to donate for banner space or to access our archives for research.

She will also join neversickanymore at Drug Studies: focusing on sorting through all of our research studies, matching older studies up with publications, to illustrate how Bluelight is contributing to research more broadly.

toscablue joins us from Amsterdam - she has held a variety of research assistant roles in the drugs area, most recently working at the EMCDDA, so she has some on-ground drug-research skills to offer.

So, thanks and welcome!

The Journal of Substance Use recently published a paper which represented the international harm reduction community Bluelight.org as a website used for sourcing drugs.

Yet this article’s conclusions were based only on two case studies, with no attempt to review the existing literature regarding Bluelight. Many in this community would be aware of these studies which show that most people come here to learn how to use drugs more safely, that our members actively disseminate information to warn people of highly dangerous adulterated drugs, and that we regularly collaborate with researchers to provide a leading-edge source of data for monitoring new drug trends. Bluelight is regularly cited as a valued source of harm reduction information for people who use drugs.

Bluelight goes to great lengths to avoid hosting discussions about drug sources. Moderators delete all discussions that could be related to sourcing drugs as quickly as they can.

Our response to this journal...